Articles

Activists plan to protest WellPoint political giving at meeting

A mix of union groups, activist investors and single-payer advocates will call for increased disclosure from WellPoint, and some investment funds will vote against WellPoint board members who they say have failed to exercise proper oversight of WellPoint’s political spending.

Read More

Lilly to try again to remove poison-pill provisions

Eli Lilly and Co.’s board is once again recommending the removal of a provision that makes the company an almost impossible target for hostile takeovers. The same proposal has fallen slightly short at each of the past two annual shareholder meetings.

Read More

Cracker Barrel rebuffs Biglari

Cracker Barrel shareholders appear to have rejected Sardar Biglari’s move to join the restaurant chain’s board, but stopped short of passing a “poison pill” plan that would deter outside investors from taking over the business.

Read More

After another loss, JA plans for recovery

The not-for-profit hangs its hopes on efforts including more aggressive fundraising after reporting a $389,000 deficit for
its 2010 fiscal year. “It’s been a rough spell,” said CEO Jennifer Burk.

Read More

Steak n Shake unveils new restaurant prototype

The company now known as Biglari Holdings Inc. on Thursday unveiled a new prototype for future Steak n Shake restaurants.
CEO Sardar Biglari said the goal is to open about 1,500 new franchise locations in the coming years.

Read More

Steak n Shake CEO woos investors in New York City

Steak n Shake Co. doesn't operate a single restaurant in New York City, where it is hosting its annual meeting Thursday.
But the world financial capital is chock full of high-profile investors intrigued by Steak n Shake CEO Sardar Biglari's
plans to harvest cash from the 485-location restaurant chain and deploy it on other investments.

Read More